|
Methyl-Carbamic Acid Ethyl Ester
|
DB02856 |
|
|
4-Androstenediol
|
DB01526 |
|
|
D-Proline
|
DB02853 |
[D-proline is an isomer of the naturally occurring amino acid, L-Proline. D-amino acids have been found in relatively high abundance in human plasma and saliva [A19262]. These amino acids may be of bacterial origin, but there is also evidence that they are endogenously produced through amino acid racemase activity [A19263].] |
|
Clostebol
|
DB01521 |
|
|
Aetiocholanolone
|
DB02854 |
[The 5-beta-reduced isomer of androsterone. Etiocholanolone is a major metabolite of testosterone and androstenedione in many mammalian species including humans. It is excreted in the urine. [PubChem]] |
|
Tenocyclidine
|
DB01520 |
[Tenocyclidine (TCP, thienyl cyclohexylpiperidine) is a dissociative anesthetic drug with stimulant and hallucinogenic effects. It is more potent than phencyclidine and hence, this drug was classified under the schedule 1 in 1970.] |
|
Clonitazene
|
DB01523 |
|
|
Thiocamphor
|
DB02851 |
|
|
Domoic Acid
|
DB02852 |
|
|
Betacetylmethadol
|
DB01522 |
[A narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence. [PubChem]] |
|
DAS869
|
DB02850 |
|
|
Alginic acid
|
DB13518 |
[Alginic acid, also referred to as algin or alginate, is a hydrophilic or anionic polysaccharide isolated from certain brown seaweed (_Phacophycae_) via alkaline extraction. It is present in cell walls of brown algae where it forms a viscous gel when binding with water. Alginic acid is a linear polymer consisted of L-glucuronic acid and D-mannuronic acid residues connected via 1,4-glycosidic linkages [A32961]. Available in different types of salt, alginic acid has been used in a variety of uses in food, cosmetics and pharmaceu-tical products for over 100 years [A32961]. Alginic acid is an FDA-approved food ingredient in soup and soup mixes as an emulsifier, thickener, and stabilizer [L2693]. It is also available in oral dietary supplements and is found in antacids such as Gaviscon to inhibit gastroesophageal reflux by creating a physical barrier in presence of gastric acid [F46]. Alginate-based raft-forming formulations in the management of heartburn and gastric acid reflux have been used worldwide for over 30 years [A32961].] |
|
Nebicapone
|
DB14849 |
[Nebicapone is under investigation in clinical trial NCT03097211 (Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg).] |
|
Cerium oxalate
|
DB13519 |
|
|
Pranoprofen
|
DB13514 |
|
|
Bimiralisib
|
DB14846 |
[Bimiralisib is under investigation in clinical trial NCT02723877 (PQR309 and Eribulin in Metastatic HER2 Negative and Triple-negative Breast Cancer (PIQHASSO)).] |
|
Filgotinib
|
DB14845 |
[Filgotinib is under investigation in clinical trial NCT03100942 (Safety and Efficacy Study of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome).] |
|
Levomethadone
|
DB13515 |
|
|
Tibulizumab
|
DB14848 |
[Tibulizumab is under investigation in clinical trial NCT03736772 (A Study of LY3090106 in Japanese and Caucasian Healthy Participants).] |
|
Clodantoin
|
DB13516 |
|
